Saturday, 19 Sep 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Finance
Clinical trial results
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Fineline Cube
Follow:
14435
Articles
Company
Deals
Forlong Biotechnology Secures Series A Funding for Protein Drug Development
January 20, 2025
Company
Deals
Zhimeng Biopharma Signs Global Licensing Deal with GSK for TLR8 Agonist CB06
January 20, 2025
Company
Deals
Haisco Pharmaceutical Announces Public Offering for Clinical Studies
January 20, 2025
Company
Drug
BDgene’s CRISPR-Cas9 Therapy BD111 Accepted for CDE Review
January 20, 2025
Company
Drug
JunTop Biosciences’ COVID-19 Therapy Mindewei Priced at RMB 795 per Course
January 20, 2025
Company
Deals
Ji Xing Pharmaceuticals Acquires Global Rights to PhaseBio’s PB6440
January 20, 2025
Company
Drug
Mabwell’s Novel ADC 9MW2921 Accepted for NMPA Review
January 20, 2025
Company
Amgen Reports Q4 and Full-Year 2022 Financials with Global Sales Growth
January 20, 2025
Company
GSK Reports Strong Q4 and Full-Year 2022 Financials Amid Strategic Shift
January 20, 2025
Policy / Regulatory
China’s NMPA Releases 64th Batch of Reference Drugs for Generic Quality Consistency Evaluation
January 20, 2025
Company
Drug
Bristol-Myers Squibb’s Ozanimod Approved in China for Multiple Sclerosis
January 20, 2025
Company
Roche Reports 2% YOY Growth in 2022; Ocrevus and Hemlibra Drive Sales
January 20, 2025
1
2
…
1,037
1,038
1,039
1,040
1,041
…
1,202
1,203
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
